NeuroNode Trilogy

0/5

Manufacturer

Base Price

NeuroNode Trilogy, the latest system from Control Bionics combining three powerful access methods, provides a lifetime solution for those living with paralysis and loss of speech. Faster communication, complete control. Powered by Grid 3.

Characteristics
Activities
Conditions

Full Description

WHAT IS THE NEURONODE TRILOGY?
The NeuroNode Trilogy is a 3-in-1 solution for those living with paralysis and loss of speech.

Combining touch control, eye control, and mind control, the NeuroNode Trilogy is finally the solution that fits to the users needs as they change. Combining control methods allows you to significantly increase your speed and communication output. In initial internal testing, users were able to communicate 133% faster with the NeuroNode Trilogy.

WHAT IS THE NEURONODE3?

At the heart of the NeuroNode Trilogy is the NeuroNode3, the latest generation of the world’s leading wearable EMG control device. The NeuroNode3 is packed with new added benefits – making it more intuitive and flexible than ever.

– Smaller, lighter, and even more durable
– Improved battery life for over 24 hours of use with hassle-free charging
– Adhesive-free, wearable solution with the new NeuroBand

The NeuroNode3 now offers the combined power of its EMG + NEW 3D Spatial Control. This new control set allows users to choose EMG or Spatial control to access the NeuroNode Trilogy, all in one small, wearable device.

WHAT IS EMG?

EMG, or “electromyography,” is the measurement of electrical activity associated with the activation of a muscle group. While EMG technology has been used in clinical and research settings for decades, we have spent 10 years advancing the EMG technology inside the NeuroNode3 specifically for people with severe motor impairments.

EMG control is a powerful access method for a wide range of conditions with many benefits:

– Entirely independent of body position and light condition
– Less tiring and more consistent than traditional access methods
– Completely wireless, making it easier for caregivers to work around

WHY CHOOSE THE NEURONODE TRILOGY?

While there are many great AAC solutions on the market, the NeuroNode Trilogy is designed to make your life easier. Combining three methods of control with Grid 3 software means one AAC software solution, one SLP evaluation, and one funding application. For super-users this means the fastest AAC solution around, and for those with progressive illnesses it means a solution that changes alongside their needs.

The Control Bionics Team supports the NeuroNode Trilogy around the clock. Give us a call any time of day and talk to a real person; most issues can be resolved within 3 minutes!

Cognitive Abilities

NeuroNode Trilogy combined with the Grid 3 software is well suited to help those with cognitive difficulties communicate. The hardware is easy to use and can be setup to be intuitive for the end user. The software helps guide the user to communicate effectively.

Functional Abilities

This communication system is a great solution for users seeking a flexible, lightweight communication system for use at-home and on the go. This system is used by people living with paralysis and loss of speech.

Environment

The NeuroNode Trilogy can be used indoors or outdoors and can connect to a motorized wheelchair, floor mount, bedside mount, or table mount.

Activities

Small and lightweight, the NeuroNode can be used for communication in a home setting, hospital setting, or on the go.
Warnings

Please speak with your healthcare provider and schedule an in-person consultation before purchasing this product, to evaluate whether it is truly the best option for you.

Vendors

evika uses affiliate links when available

Control Bionics
Price Not Available
Funding Sources
ADP (Assistive Devices Program) Ontario
ADP is Ontario's Assistive Devices funding program.

Product Code: CC0001664
Covered Price: CA$ 19,995
Category: Communication Aids – Communication Aids (Clinics) – Integrated System

Medicare (DME MAC)
Medicare is a national health insurance program in the United States, begun in 1965 under the Social Security Administration (SSA) and now administered by the Centers for Medicare and Medicaid Services (CMS). It primarily provides health insurance for Americans aged 65 and older, but also for some younger people with disability status as determined by the SSA, including people with end stage renal disease and amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).

HCPCS Code: E2510
Product Category: SGD w multi methods msg/accs

Reviews

There are no reviews yet.

Be the first to review “NeuroNode Trilogy”

Your email address will not be published. Required fields are marked *

Loading...